クラスIIのHDACsと心筋縮を調節するためのリドックス依存経路
Tetsuro Ago1, Tong Liu, Peiyong Zhai
1Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103, USA.
Cell
|June 17, 2008
まとめ
ティオレドキシン1 (Trx1) はヒストン脱酸化酵素 (HDACs) を改変することによって,心筋縮における酸化ストレスを軽減します. この酸化還元調節は,HDACの核輸出を防止し,心臓病の新たな治療標的を提供している.
科学分野:
- 分子生物学は分子生物学である.
- 心血管科学の研究について
- レドックス生物学 レドックス生物学
背景:
- チオレドキシン1 (Trx1) は,細胞の酸化還元バランスの重要な調節体であり,細胞の成長と死に影響を与えます.
- 心筋の大量の増加である心筋縮は,しばしば心不全につながる適応不良の反応です.
- クラスIIヒストン脱酸化酵素 (HDACs) は,心筋縮の重要な負の調節因子である.
研究 の 目的:
- Trx1が心筋縮を弱める分子メカニズムを解明する.
- 心筋縮中のクラスIIHDACsの調節におけるレドックス変異の役割を調査する.
主な方法:
- DnaJb5とクラスIIのHDACのTrx1媒介調節が研究されている.
- DnaJb5とHDAC4.4における特定のシステイン残基のリドックス変異 (酸化と還元) を分析した.
- これらの改変がタンパク質とタンパク質の相互作用と細胞下局所化 (核輸出) に与える影響を評価した.
主要な成果:
- Trx1はDnaJb5を調節し,DnaJb5とクラスIIHDACと複合体を形成する.
- Trx1は,高圧刺激下でDnaJb5 (Cys-274/Cys-276) とHDAC4 (Cys-667/Cys-669) の酸化システイン残基を減少させます.
- DnaJb5-HDAC4の相互作用には,DnaJb5システインの減少が不可欠であり,HDAC4システインの減少は,その核輸出を抑制する.
結論:
- 心臓高縮症は,クラスIIのHDACのリドックス改変を含む新しいTrx1感受性メカニズムによって調節されます.
- Trx1によるHDAC4のレドックス変異は,その核サイトプラズマのシャトリングを調節し,高縮性シグナル伝達に影響を与える.
- この研究は,心筋縮におけるリドックス経路を標的とした潜在的な治療戦略を明らかにしています.
関連する概念動画
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Redox Reactions
1.2K
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
1.2K
Cellular Adaptation II: Hypertrophy
54
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
54


